Advertisement
Advertisement

SONN

SONN logo

Sonnet BioTherapeutics Holdings Inc

1.69
USD
-0.03
-1.74%
Dec 18, 13:48 UTC -5
Open

Sonnet BioTherapeutics Holdings Inc Profile

About

Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.

Info & Links

CEO

Pankaj Mohan

Headquarters

100 OVERLOOK CENTER, SUITE 102
PRINCETON, NJ 08540, UNITED STATES

Auditor

KPMG LLP

Share holders

76

Employees

12

Sonnet BioTherapeutics Holdings Inc Statistics

Valuation Measures

Market Capitalization2

1.15M

Enterprise Value

-2.41M

Enterprise Value/EBITDA(ttm)

0.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.56

Price to Book(mrq)

0.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-4035.66%

Return on Equity(ttm)

-398.45%

Return on Invested Capital(ttm)

1459.66%

Return on Assets(ttm)

-142.16%

Income Statement

Revenue(ttm)

55.90K

Revenue Per Share(ttm)

0.09

Gross Profit(ttm)

55.90K

EBITDA(ttm)3

-12.20M

Net Income Available to Common(ttm)

-7.99M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.44

52-Week Change

-86.96%

S&P 500 52-Week Change

25.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

650.31K

Dividend Yield

0.00%

Float4

669.00K

% Held by Insiders

2.00%

% Held by Institutions

9.45%

Balance Sheet

Total Cash(mrq)

3.55M

Total Cash Per Share(mrq)

5.47

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.65%

Quick Ratio(mrq)

1.65%

Book Value Per Share(mrq)

4.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.63

Free Cash Flow(ytd)

-5.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement